BRITTANI REED: Open Payments
NPI 1316596075 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,589 in 67 payments from 29 companies in 2025. Trend: 2023 $1,073 · 2024 $1,661 · 2025 $1,589
Food & beverage: $1,312Education: $278
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 19 | $245 |
| Novartis Pharmaceuticals Corporation | 6 | $168 |
| Janssen Biotech, Inc. | 5 | $160 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $80 |
| GENZYME CORPORATION | 2 | $69 |
| Caris MPI, Inc. | 1 | $59 |
| Dendreon Pharmaceuticals LLC | 1 | $58 |
| ABBVIE INC. | 2 | $58 |
| Incyte Corporation | 3 | $54 |
| Exelixis Inc. | 2 | $52 |
Products named: IBRANCE, RYBREVANT, KISQALI, PLUVICTO, MI CANCER SEEK, PROVENGE, ENHERTU, CABOMETYX.
Industry payments across MO — which companies pay providers there.
